Raymond James Trust N.A. Fulgent Genetics, Inc. Transaction History

Raymond James Trust N.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 03, 2021	SELL	$59.3 - $183.85 $20 Million - $62.1 Million	-337,659 Closed	0 $0
Q4 2020 Jan 13, 2021	SELL	$31.01 - $52.1 $27.9 Million - $47 Million	-901,291 Reduced 72.75%	337,659 $17.6 Million
Q3 2020 Oct 14, 2020	BUY	$15.89 - $50.51 $7.16 Million - $22.8 Million	450,599 Added 57.16%	1,238,950 $49.6 Million
Q2 2020 Jul 16, 2020	BUY	$8.89 - $18.28 $4.01 Million - $8.25 Million	451,351 Added 133.93%	788,351 $12.6 Million
Q1 2020 Apr 17, 2020	SELL	$6.75 - $19.75 $555,012 - $1.62 Million	-82,224 Reduced 19.61%	337,000 $3.63 Million
Q4 2019 Jan 14, 2020	SELL	$9.29 - $15.82 $750,409 - $1.28 Million	-80,776 Reduced 16.16%	419,224 $5.41 Million
Q3 2019 Oct 24, 2019	BUY	$5.96 - $12.81 $2.98 Million - $6.41 Million	500,000 New	500,000 $5.2 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

Stay updated on Raymond James Trust N.A. with notifications on news.